Antares Pharma (ATRS) Prices 12.5M Offering at $4/Share

Antares Pharma, Inc. (Nasdaq: ATRS) has priced a firm commitment underwritten public offering of 12,500,000 shares of the Company’s common stock at a purchase price to the public of $4.00 per share, resulting in net proceeds to the Company of $47 million (before estimated offering expenses payable by us).

Jefferies & Company, Inc. and Oppenheimer and Co. Inc. are acting as joint book-running managers for the offering. Cowen and Company, LLC and Ladenburg Thalmann & Co. Inc. are acting as the co-managers of the offering. The offering is expected to close on or about October 8, 2012, subject to customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to 1,875,000 additional shares of common stock.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nucor (NUE) files mixed shelf
• Saratoga Investment prices $85M in notes due 2031 at 8.00%
• Karman Line Acquisition closes $200M IPO on Nasdaq